Picard Medical, Inc. 8-K

What Happened

• Picard Medical, Inc. announced on March 2, 2026 (Regulation FD disclosure) that its Vice President of Clinical Affairs, Dr. Andre Simon, will deliver three presentations at the Technology and Heart Failure Therapeutics 2026 conference, taking place March 2–4, 2026 in Boston, Massachusetts. The company furnished a press release dated March 2, 2026 as Exhibit 99.1.

Key Details

• Presenter: Dr. Andre Simon, Vice President of Clinical Affairs at Picard Medical.
• Presentations: Three scheduled talks at Technology and Heart Failure Therapeutics 2026.
• Conference: March 2–4, 2026, Boston, Massachusetts.
• Filing: Announcement made as a Regulation FD disclosure; the press release is furnished as Exhibit 99.1 and the disclosure is not deemed “filed” under the Exchange Act.

Why It Matters

• This disclosure highlights company visibility in a major cardiology/heart‑failure forum and signals active clinical engagement; such presentations can raise awareness among clinicians, investigators, and potential partners.
• The filing does not report financial results, management changes, or material corporate actions—investors should view it as a public communications/clinical outreach item rather than a financial disclosure.